Comparison of educational interventions for mental health consumers receiving psychotropic medication

Rhonda D Griffiths, Ritin S Fernandez, Maria S Mostacchi, Venita Evans
{"title":"Comparison of educational interventions for mental health consumers receiving psychotropic medication","authors":"Rhonda D Griffiths,&nbsp;Ritin S Fernandez,&nbsp;Maria S Mostacchi,&nbsp;Venita Evans","doi":"10.1111/j.1479-697X.2004.00007.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p><b>Background </b> One in four people globally will be affected by mental disorders at some point in their life. Currently approximately 450 million people worldwide suffer from this condition thereby placing mental health disorders among the leading cause of illness. Although treatment with psychotropic medication for specific psychological interventions has been demonstrated to be beneficial, it is also associated with relapse due to non-adherence to the medication regime. Factors associated with non-compliance include inadequate knowledge of the condition and the side-effects of the drugs. However, there is still some debate amongst psychiatrists as to the relative benefits of informing consumers about the side-effects.</p>\n <p><b>Objectives </b> The objective of this review was to systematically assess the literature and present the best available evidence that investigated the efficacy of educational interventions, relating to psychotropic medications, for consumers with a mental health disorder.</p>\n <p><b>Search strategy </b> A literature search was performed using the following databases Medline (1966–2000), CINAHL (1982–2002), EMBASE (1980–2002) ProQuest, Psychlit and the Cochrane Controlled Trials Register (Issue 2, 2002 of Cochrane Library). In addition, the reference lists of relevant trials and conference proceedings were also scrutinised. No language restrictions were applied. Experts and investigators were contacted to elicit further information.</p>\n <p><b>Selection criteria </b> All relevant randomised controlled trials that investigated the effectiveness of providing education and the methods to provide education to adult consumers with a mental illness were eligible for inclusion in the study.</p>\n <p><b>Data collection and analysis </b> Eligibility of the trials for inclusion in the review, details of eligible trials and the methodological quality of the trials was assessed jointly by two reviewers. All information was verified by a third reviewer. Odds ratio for dichotomous data and a weighted mean difference for continuous data were calculated with 95% confidence intervals. Where synthesis was inappropriate a narrative overview was undertaken.</p>\n <p><b>Results </b> Twenty-one studies were included in this review. Knowledge was assessed in 15 studies. Compliance was assessed in 13 studies. Relapse was assessed in five studies and insight was assessed in six studies. Those patients who were provided with education demonstrated a significant increase in the level of knowledge and compliance compared to those who were not. However, there was no difference in the incidence of relapse and insight in those who were provided education. A structured education session using both written and verbal methods followed by discussion was demonstrated to be effective. The evidence suggests that consumers who were provided multiple education sessions had greater knowledge gains in the short term (up to 1 month); however, the effectiveness of multiple sessions in the long term (2 years) was inconclusive. The review provides evidence that multiple education sessions are better than single education sessions in improving knowledge relating to medications and insight into illness.</p>\n <p><b>Conclusions </b> Evidence from the trials demonstrates that structured educational interventions delivered at frequent intervals are useful as part of the treatment program for people with a mental illness. More well-designed and reported randomised studies investigating the efficacy of education are urgently needed.</p>\n </div>","PeriodicalId":100738,"journal":{"name":"JBI Reports","volume":"2 1","pages":"1-44"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBI Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1479-697X.2004.00007.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background One in four people globally will be affected by mental disorders at some point in their life. Currently approximately 450 million people worldwide suffer from this condition thereby placing mental health disorders among the leading cause of illness. Although treatment with psychotropic medication for specific psychological interventions has been demonstrated to be beneficial, it is also associated with relapse due to non-adherence to the medication regime. Factors associated with non-compliance include inadequate knowledge of the condition and the side-effects of the drugs. However, there is still some debate amongst psychiatrists as to the relative benefits of informing consumers about the side-effects.

Objectives The objective of this review was to systematically assess the literature and present the best available evidence that investigated the efficacy of educational interventions, relating to psychotropic medications, for consumers with a mental health disorder.

Search strategy A literature search was performed using the following databases Medline (1966–2000), CINAHL (1982–2002), EMBASE (1980–2002) ProQuest, Psychlit and the Cochrane Controlled Trials Register (Issue 2, 2002 of Cochrane Library). In addition, the reference lists of relevant trials and conference proceedings were also scrutinised. No language restrictions were applied. Experts and investigators were contacted to elicit further information.

Selection criteria All relevant randomised controlled trials that investigated the effectiveness of providing education and the methods to provide education to adult consumers with a mental illness were eligible for inclusion in the study.

Data collection and analysis Eligibility of the trials for inclusion in the review, details of eligible trials and the methodological quality of the trials was assessed jointly by two reviewers. All information was verified by a third reviewer. Odds ratio for dichotomous data and a weighted mean difference for continuous data were calculated with 95% confidence intervals. Where synthesis was inappropriate a narrative overview was undertaken.

Results Twenty-one studies were included in this review. Knowledge was assessed in 15 studies. Compliance was assessed in 13 studies. Relapse was assessed in five studies and insight was assessed in six studies. Those patients who were provided with education demonstrated a significant increase in the level of knowledge and compliance compared to those who were not. However, there was no difference in the incidence of relapse and insight in those who were provided education. A structured education session using both written and verbal methods followed by discussion was demonstrated to be effective. The evidence suggests that consumers who were provided multiple education sessions had greater knowledge gains in the short term (up to 1 month); however, the effectiveness of multiple sessions in the long term (2 years) was inconclusive. The review provides evidence that multiple education sessions are better than single education sessions in improving knowledge relating to medications and insight into illness.

Conclusions Evidence from the trials demonstrates that structured educational interventions delivered at frequent intervals are useful as part of the treatment program for people with a mental illness. More well-designed and reported randomised studies investigating the efficacy of education are urgently needed.

接受精神药物治疗的心理健康消费者的教育干预比较
背景全球四分之一的人在一生中的某个时刻会受到精神障碍的影响。目前,全世界约有4.5亿人患有这种疾病,从而将心理健康障碍列为疾病的主要原因之一。尽管针对特定心理干预的精神药物治疗已被证明是有益的,但由于不遵守药物制度,它也与复发有关。与不合规相关的因素包括对病情和药物副作用的了解不足。然而,对于告知消费者副作用的相对益处,精神科医生之间仍存在一些争论。目的本综述的目的是系统地评估文献,并提供最佳可用证据,调查与精神药物相关的教育干预措施对精神健康障碍消费者的疗效。检索策略使用以下数据库Medline(1966–2000)、CINAHL(1982–2002)、EMBASE(1980–2002)ProQuest、Psychlit和Cochrane对照试验登记册(Cochrane Library 2002年第2期)进行文献检索。此外,还仔细审查了相关审判和会议记录的参考名单。没有语言限制。联系了专家和调查人员以获取进一步信息。选择标准所有相关的随机对照试验都有资格纳入研究,这些试验调查了为患有精神疾病的成年消费者提供教育的有效性和提供教育的方法。数据收集和分析纳入审查的试验的资格、合格试验的细节和试验的方法质量由两名审查人员联合评估。所有信息均由第三位审查员核实。以95%置信区间计算二分数据的比值比和连续数据的加权平均差。如果综合不合适,则进行叙述性概述。结果本综述共纳入21项研究。在15项研究中对知识进行了评估。对13项研究的依从性进行了评估。在五项研究中评估了复发,在六项研究中对洞察力进行了评估。与未接受教育的患者相比,接受了教育的患者的知识水平和依从性显著提高。然而,接受教育者的复发率和洞察力没有差异。采用书面和口头方法,然后进行讨论的结构化教育课程被证明是有效的。证据表明,接受多次教育的消费者在短期内获得了更多的知识(高达1 月);然而,从长远来看,多次会议的有效性(2 年)没有结论。该综述提供的证据表明,在提高与药物相关的知识和对疾病的洞察力方面,多次教育比单一教育要好。结论来自试验的证据表明,作为精神疾病患者治疗计划的一部分,经常进行的结构化教育干预是有用的。迫切需要更精心设计和报道的随机研究来调查教育的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信